Share on StockTwits

IsoRay (NYSE:ISR) saw a significant drop in short interest in August. As of August 15th, there was short interest totalling 4,746,736 shares, a drop of 5.2% from the July 31st total of 5,008,602 shares, Analyst Ratings.Net reports. Based on an average trading volume of 923,160 shares, the short-interest ratio is currently 5.1 days. Currently, 8.8% of the shares of the stock are short sold.

Separately, analysts at Maxim Group initiated coverage on shares of IsoRay in a research note on Wednesday, July 16th. They set a “buy” rating and a $5.00 price target on the stock.

Shares of IsoRay (NYSE:ISR) opened at 2.48 on Wednesday. IsoRay has a 52-week low of $0.44 and a 52-week high of $3.77. The stock’s 50-day moving average is $2.58 and its 200-day moving average is $2.21. The company’s market cap is $134.3 million.

IsoRay, Inc (NYSE:ISR) is engaged in the development, manufacturing and selling of isotope-based medical products and devices for the treatment of cancer and other malignant diseases.

Receive News & Ratings for IsoRay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IsoRay and related companies with Analyst Ratings Network's FREE daily email newsletter.